Project: Use of recombinant DNA technology for the optimalization of immune responses: a)development of an anti-influenza A virus vaccine b)tumor immunotherapy by introduction of immunomodulating lymphokines.
- project duration
- 31-DEC-99 – 31-DEC-99
- A) Using the technology of recombinant DNA, expression in heterologous systems and protein engineering we try to develop a vaccin providing protection against a broader spectrum of influenza A virus strains. B) T-lymphocytes, directed against an antigen present on different tumor cell lines were isolated. This tumorspecificity will be applied to direct the lymphokines to the tumor site.